The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-Ethylphenyl)-1-methyl-N-(methylsulfonyl)-1H-indole-6-carboxamide ID: ALA4536400
PubChem CID: 132051626
Max Phase: Preclinical
Molecular Formula: C19H20N2O3S
Molecular Weight: 356.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCc1ccc(-c2cn(C)c3cc(C(=O)NS(C)(=O)=O)ccc23)cc1
Standard InChI: InChI=1S/C19H20N2O3S/c1-4-13-5-7-14(8-6-13)17-12-21(2)18-11-15(9-10-16(17)18)19(22)20-25(3,23)24/h5-12H,4H2,1-3H3,(H,20,22)
Standard InChI Key: WFHMYKDPZFLJNW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
40.5253 -1.3991 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.9421 -2.1131 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
41.3505 -1.3966 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.2330 -2.5305 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.6567 -2.5251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5185 -2.1224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8094 -2.5398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.5131 -1.3011 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.0972 -2.1287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1129 -3.7713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8187 -3.3564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3935 -3.3675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3853 -2.5499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6050 -2.3021 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.1334 -2.9691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6181 -3.6266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3448 -1.5233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3734 -4.4104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5724 -4.5851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3276 -5.3681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8807 -5.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6860 -5.7936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9312 -5.0109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6352 -6.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8375 -6.9316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
4 6 1 0
6 7 1 0
6 8 2 0
7 9 2 0
9 13 1 0
12 10 1 0
10 11 2 0
11 7 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 2 0
16 12 1 0
14 17 1 0
16 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 356.45Molecular Weight (Monoisotopic): 356.1195AlogP: 3.10#Rotatable Bonds: 4Polar Surface Area: 68.17Molecular Species: ACIDHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.12CX Basic pKa: ┄CX LogP: 3.24CX LogD: 2.29Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -0.89
References 1. Luo G, Chen L, Easton A, Newton A, Bourin C, Shields E, Mosure K, Soars MG, Knox RJ, Matchett M, Pieschl RL, Post-Munson DJ, Wang S, Herrington J, Graef J, Newberry K, Sivarao DV, Senapati A, Bristow LJ, Meanwell NA, Thompson LA, Dzierba C.. (2019) Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective NaV1.7 Inhibitors for the Treatment of Pain., 62 (2): [PMID:30576602 ] [10.1021/acs.jmedchem.8b01550 ]